Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis

[1]  S. Kesari,et al.  Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: Co-localization of CD8+ T cells with JCV-infected glial cells , 2006, Journal of NeuroVirology.

[2]  A. d’Arminio Monforte,et al.  Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study , 2001, Journal of NeuroVirology.

[3]  I. Koralnik,et al.  Spinal cord lesions of progressive multifocal leukoencephalopathy in an acquired immunodeficiency syndrome patient , 2011, Journal of NeuroVirology.

[4]  A. Antinori,et al.  Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: Data from the Italian Registry Investigative Neuro AIDS (IRINA) , 2011, Journal of NeuroVirology.

[5]  D. Clifford,et al.  The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: Defining a consensus terminology , 2011, Journal of NeuroVirology.

[6]  A. Aksamit.  Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside , 2011, Journal of NeuroVirology.

[7]  R. D. Pasquier,et al.  Inflammatory reaction in progressive multifocal leukoencephalopathy: Harmful or beneficial? , 2011, Journal of NeuroVirology.

[8]  E. Major,et al.  A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region , 2011, Journal of NeuroVirology.

[9]  J. Delfraissy,et al.  Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: A monocenter observational study with clinical and JC virus load monitoring , 2011, Journal of NeuroVirology.

[10]  D. Clifford,et al.  Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[11]  D. Clifford,et al.  Natalizumab-associated progressive multifocal leukoencephalopathy. , 2012 .

[12]  L. Calabrese,et al.  Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases. , 2009, Arthritis and rheumatism.

[13]  D. Clifford,et al.  Determinants of survival in progressive multifocal leukoencephalopathy , 2009, Neurology.

[14]  I. Koralnik,et al.  Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  Igor J. Koralnik,et al.  Case 14-2004 , 2009 .

[16]  J. Miro,et al.  Progressive multifocal leukoencephalopathy in HIV-1 infection. , 2009, The Lancet. Infectious diseases.

[17]  D. Clifford,et al.  Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. , 2009, The New England journal of medicine.

[18]  L. Ngo,et al.  Asymptomatic reactivation of JC virus in patients treated with natalizumab. , 2009, The New England journal of medicine.

[19]  E. Major,et al.  Progressive multifocal leukoencephalopathy after natalizumab monotherapy. , 2009, The New England journal of medicine.

[20]  M. Barnett,et al.  What lies beneath the tent? JC-virus cerebellar granule cell neuronopathy complicating sarcoidosis , 2009, Journal of Clinical Neuroscience.

[21]  K. Tyler,et al.  Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists. , 2009, Archives of dermatology.

[22]  T. Montine,et al.  Depletion of B lymphocytes from cerebral perivascular spaces by rituximab. , 2009, Archives of neurology.

[23]  J. Lowe,et al.  Atypical progressive multifocal leukoencephalopathy associated with an unusual JC polyomavirus mutation. , 2009, Archives of neurology.

[24]  Matthew P. Anderson,et al.  Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons , 2009, Annals of neurology.

[25]  M. Battegay,et al.  Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  David Green,et al.  Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. , 2009, Blood.

[27]  K. Tyler,et al.  Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study. , 2009, Archives of neurology.

[28]  J. McArthur,et al.  PML-IRIS in patients with HIV infection , 2009, Neurology.

[29]  I. Koralnik,et al.  Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. , 2009, The Journal of infectious diseases.

[30]  Adrian Egli,et al.  Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. , 2009, The Journal of infectious diseases.

[31]  K. Simon,et al.  Identification and Characterization of Mefloquine Efficacy against JC Virus In Vitro , 2009, Antimicrobial Agents and Chemotherapy.

[32]  R. Ransohoff,et al.  Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function , 2009, Neurology.

[33]  J. McArthur,et al.  Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy. , 2009, Archives of neurology.

[34]  N. Bhardwaj,et al.  Efficient in vitro expansion of JC virus-specific CD8(+) T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy. , 2009, Virology.

[35]  S. Kesari,et al.  Frequent Infection of Cerebellar Granule Cell Neurons by Polyomavirus JC in Progressive Multifocal Leukoencephalopathy , 2009, Journal of neuropathology and experimental neurology.

[36]  R. Lonergan,et al.  Asymptomatic reactivation of JC virus in patients treated with natalizumab. , 2009, The New England journal of medicine.

[37]  G. Kronborg,et al.  Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. , 2009, The Journal of infectious diseases.

[38]  C. Marra,et al.  Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis , 2008, AIDS.

[39]  J. Gordon,et al.  BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[40]  F. Eichler,et al.  Cortical demyelination in PML and MS , 2008, Neurology.

[41]  C. Cunningham-Rundles,et al.  Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. , 2007, The Journal of infectious diseases.

[42]  R. Ransohoff,et al.  Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus–negative patients , 2007, Annals of neurology.

[43]  C. Feldman,et al.  Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options , 2007, AIDS research and therapy.

[44]  Yvonne W Wu,et al.  JC virus granule cell neuronopathy in a child with CD40 ligand deficiency. , 2007, Pediatric neurology.

[45]  D. Clifford,et al.  Frequency and Phenotype of JC Virus-Specific CD8+ T Lymphocytes in the Peripheral Blood of Patients with Progressive Multifocal Leukoencephalopathy , 2007, Journal of Virology.

[46]  J. Stockman.  Progressive Multifocal Leukoencephalopathy Complicating Treatment With Natalizumab and Interferon Beta-1a for Multiple Sclerosis , 2007 .

[47]  G. Sevlever,et al.  Immune reconstitution inflammatory syndrome associated with PML in AIDS: A treatable disorder , 2006, Neurology.

[48]  A. Bar-Or,et al.  Altered CD 4 / CD 8 T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis , 2006 .

[49]  T. Kurth,et al.  Characteristics and antecedents of progressive multifocal leukoencephalopathy in an insured population , 2006, Neurology.

[50]  Xin Dang,et al.  A granule cell neuron-associated JC virus variant has a unique deletion in the VP1 gene. , 2006, The Journal of general virology.

[51]  G. Martinelli,et al.  Peripheral T-lymphocyte subsets in patients treated with Rituximab–Chlorambucil combination therapy for indolent NHL , 2006, Annals of Hematology.

[52]  I. Koralnik.  Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name? , 2006, Annals of neurology.

[53]  S. Cepok,et al.  Immune surveillance in multiple sclerosis patients treated with natalizumab , 2006, Annals of neurology.

[54]  F. Barkhof,et al.  Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. , 2006, The New England journal of medicine.

[55]  M. Lipman,et al.  Immune reconstitution inflammatory syndrome in HIV , 2006, Current opinion in infectious diseases.

[56]  F. Drislane,et al.  Seizures and their outcome in progressive multifocal leukoencephalopathy , 2006, Neurology.

[57]  A. Verma.  Progressive Multifocal Leukoencephalopathy in a Patient Treated With Natalizumab , 2006 .

[58]  G. Lichtenstein.  Progressive Multifocal Leukoencephalopathy After Natalizumab Therapy for Crohn's Disease , 2006 .

[59]  A. Bar-Or,et al.  Altered CD 4 / CD 8 T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis , 2006 .

[60]  J. Goedert,et al.  Antibodies to JC and BK viruses among persons with non‐Hodgkin lymphoma , 2005, International journal of cancer.

[61]  E. Lazaro,et al.  JC virus meningitis in a patient with systemic lupus erythematosus , 2005, Lupus.

[62]  C. Otis,et al.  Granule Cell Loss in AIDS-Associated Progressive Multifocal Leukoencephalopathy , 2005 .

[63]  P. Randhawa,et al.  Quantitation of DNA of polyomaviruses BK and JC in human kidneys. , 2005, The Journal of infectious diseases.

[64]  A. Gurtman,et al.  JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy , 2005, Annals of neurology.

[65]  E. Graviss,et al.  Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy , 2005, AIDS.

[66]  F. Gray,et al.  Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy , 2005, Acta Neuropathologica.

[67]  C. Otis,et al.  Images in pathology: granule cell loss in AIDS-associated progressive multifocal leukoencephalopathy. , 2005, International journal of surgical pathology.

[68]  F. Scaravilli,et al.  Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. , 2005, Journal of neurovirology.

[69]  B. Roth,et al.  The Human Polyomavirus, JCV, Uses Serotonin Receptors to Infect Cells , 2004, Science.

[70]  J. Schmitz,et al.  Detection of JC Virus-Specific Cytotoxic T Lymphocytes in Healthy Individuals , 2004, Journal of Virology.

[71]  M. Kuroda,et al.  A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. , 2004, Brain : a journal of neurology.

[72]  M. Frosch,et al.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-2004. A 66-year-old man with progressive neurologic deficits. , 2004, The New England journal of medicine.

[73]  P. Klapper,et al.  BKV-DNA and JCV-DNA in CSF of Patients with Suspected Meningitis or Encephalitis , 2003, Infection.

[74]  M. Kuroda,et al.  Low Frequency of Cytotoxic T Lymphocytes against the Novel HLA-A*0201-Restricted JC Virus Epitope VP1p36 in Patients with Proven or Possible Progressive Multifocal Leukoencephalopathy , 2003, Journal of Virology.

[75]  K. Tyler.  The uninvited guest , 2003, Neurology.

[76]  U. de Girolami,et al.  Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual , 2003, Neurology.

[77]  N. Andrews,et al.  Population‐based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40 , 2003, Journal of medical virology.

[78]  J. Delfraissy,et al.  Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy , 2003, AIDS.

[79]  M. Lehtinen,et al.  Seroepidemiology of the human polyomaviruses. , 2003, The Journal of general virology.

[80]  W. Atwood,et al.  Oligosaccharides as Receptors for JC Virus , 2002, Journal of Virology.

[81]  D. Clifford,et al.  A PILOT STUDY OF CIDOFOVIR FOR PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN AIDS , 2002, AIDS.

[82]  J. Schmitz,et al.  Association of Prolonged Survival in HLA-A2+ Progressive Multifocal Leukoencephalopathy Patients with a CTL Response Specific for a Commonly Recognized JC Virus Epitope1 , 2002, The Journal of Immunology.

[83]  B. Roth,et al.  Cell-type specific effects of endocytosis inhibitors on 5-hydroxytryptamine2A receptor desensitization and resensitization reveal an arrestin-, GRK2-, and GRK5-independent mode of regulation in human embryonic kidney 293 cells , 2001 .

[84]  N. Letvin,et al.  JC Virus Regulatory Region Tandem Repeats in Plasma and Central Nervous System Isolates Correlate with Poor Clinical Outcome in Patients with Progressive Multifocal Leukoencephalopathy , 2001, Journal of Virology.

[85]  H. Petry,et al.  Cellular and humoral immune response in progressive multifocal leukoencephalopathy , 2001, Annals of neurology.

[86]  M. Thurnher,et al.  Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy. , 2001, AJNR. American journal of neuroradiology.

[87]  R. Miledi,et al.  Distribution of serotonin 2A, 2C and 3 receptor mRNA in spinal cord and medulla oblongata. , 2001, Brain research. Molecular brain research.

[88]  N. Letvin,et al.  JC Virus-Specific Cytotoxic T Lymphocytes in Individuals with Progressive Multifocal Leukoencephalopathy , 2001, Journal of Virology.

[89]  E. Major,et al.  Comparison of Antibody Titers Determined by Hemagglutination Inhibition and Enzyme Immunoassay for JC Virus and BK Virus , 2000, Journal of Clinical Microbiology.

[90]  A. Lazzarin,et al.  Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[91]  J. Villemure,et al.  Multiple Microvascular and Astroglial 5-Hydroxytryptamine Receptor Subtypes in Human Brain: Molecular and Pharmacologic Characterization , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[92]  C. Yiannoutsos,et al.  Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy‐proven progressive multifocal leukoencephalopathy , 1999, Annals of neurology.

[93]  A. Antinori,et al.  Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[94]  N. Letvin,et al.  JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy , 1999, Neurology.

[95]  E. Major,et al.  Detection of JC Virus DNA in Human Tonsil Tissue: Evidence for Site of Initial Viral Infection , 1998, Journal of Virology.

[96]  C. Goujard,et al.  Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. , 1998, The Journal of infectious diseases.

[97]  R. Levy,et al.  Predictive factors for prolonged survival in acquired immunodeficiency syndrome—associated progressive multifocal leukoencephalopathy , 1998, Annals of neurology.

[98]  U. Dafni,et al.  Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. , 1998, The New England journal of medicine.

[99]  M Tagliati,et al.  Cerebellar degeneration associated with human immunodeficiency virus infection , 1998, Neurology.

[100]  E. Major,et al.  The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. , 1998, Journal of neurovirology.

[101]  D. Lanska,et al.  Progressive multifocal leukoencephalopathy in patients with HIV infection. , 1998, Journal of neurovirology.

[102]  H. Kretzschmar,et al.  Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. , 1997, The Journal of infectious diseases.

[103]  E. Major,et al.  JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency , 1996, Journal of virology.

[104]  M. Bergmann,et al.  Cellular changes in the cerebellar granular layer in AIDS‐associated PML * , 1993, Neuropathology and applied neurobiology.

[105]  M. Post,et al.  Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. , 1993, Radiology.

[106]  J. Cohen,et al.  Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. , 1993, The Journal of infectious diseases.

[107]  E. Major,et al.  Interaction of the human polyomavirus, JCV, with human B-lymphocytes. , 1992, Virology.

[108]  D. Pillay,et al.  JC virus associated meningoencephalitis in an immunocompetent girl. , 1992, Archives of disease in childhood.

[109]  R. Holman,et al.  Epidemiology of progressive multifocal leukoencephalopathy in the United States , 1991, Neurology.

[110]  T. Kitamura,et al.  High incidence of urinary JC virus excretion in nonimmunosuppressed older patients. , 1990, The Journal of infectious diseases.

[111]  T. Kitamura,et al.  Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals , 1990, Journal of virology.

[112]  R. Scully,et al.  Case records of the Massachusetts General Hospital. , 1990 .

[113]  R. Frisque,et al.  Human polyomavirus JC virus genome , 1984, Journal of virology.

[114]  Richardson Ep,et al.  Progressive multifocal leukoencephalopathy: its pathological features. , 1983 .

[115]  E. Richardson,et al.  Progressive multifocal leukoencephalopathy: its pathological features. , 1983, Progress in clinical and biological research.

[116]  B. Padgett,et al.  Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. , 1973, The Journal of infectious diseases.

[117]  R. Cully,et al.  Weekly clinicopathological exercises. , 1990, The New England journal of medicine.